LEVOSEMOTIADIL
UNII 9VDH1G55NC

Substance Identification & Data

This profile provides standardized clinical and technical data for Levosemotiadil, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9VDH1G55NC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 116476-16-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9VDH1G55NC

CAS Registry Number

116476-16-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEVOSEMOTIADIL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H32N2O6S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RKXVEXUAWGRFNP-NDEPHWFRSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C87284

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

9852564

Unique identification number in the NCBI database of chemical substances.

INN ID

7303

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(OCCN(CCCOc2ccc(OC)cc2[C@@H]3Sc4c(N(C3=O)C)cccc4)C)ccc5c1OCO5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Levosemotiadil. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.